These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19671824)

  • 1. Resolution of osteonecrosis of the jaw after teriparatide [recombinant human PTH-(1-34)] therapy.
    Lau AN; Adachi JD
    J Rheumatol; 2009 Aug; 36(8):1835-7. PubMed ID: 19671824
    [No Abstract]   [Full Text] [Related]  

  • 2. More on the resolution of bisphosphonate-associated osteonecrosis of the jaw.
    Tsai KY; Huang CS; Huang GM; Yu CT
    J Rheumatol; 2010 Mar; 37(3):675; author reply 676. PubMed ID: 20197569
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple osteonecrosis of the jaw, oral bisphosphonate therapy and refractory rheumatoid arthritis (Pathological fracture associated with ONJ and BP use for osteoporosis).
    Grana J; Mahia IV; Meizoso MO; Vazquez T
    Clin Exp Rheumatol; 2008; 26(2):384-5. PubMed ID: 18565271
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diphosphonate therapy and osteonecrosis of the jaw].
    Løkken P; Skoglund LA; Skjelbred P
    Tidsskr Nor Laegeforen; 2007 Aug; 127(15):1945-7. PubMed ID: 17700737
    [No Abstract]   [Full Text] [Related]  

  • 5. Tetracycline-guided debridement and cone beam computed tomography for the treatment of bisphosphonate-related osteonecrosis of the jaw: a technical note.
    Fleisher KE; Doty S; Kottal S; Phelan J; Norman RG; Glickman RS
    J Oral Maxillofac Surg; 2008 Dec; 66(12):2646-53. PubMed ID: 19022151
    [No Abstract]   [Full Text] [Related]  

  • 6. Teriparatide therapy for alendronate-associated osteonecrosis of the jaw.
    Cheung A; Seeman E
    N Engl J Med; 2010 Dec; 363(25):2473-4. PubMed ID: 20950167
    [No Abstract]   [Full Text] [Related]  

  • 7. Bisphosphonate-related osteonecrosis of the jaw and left thumb.
    Longo R; Castellana MA; Gasparini G
    J Clin Oncol; 2009 Dec; 27(35):e242-3. PubMed ID: 19858386
    [No Abstract]   [Full Text] [Related]  

  • 8. Bisphosphonate-induced osteonecrosis of the jaw.
    Sharma V; Nagaraj S; Choksey U; Hegde A; Samant R; Balakrishnan C
    J Assoc Physicians India; 2011 Aug; 59():516-7. PubMed ID: 21887911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral bisphosphonates and osteonecrosis of the jaw: are the MHRA recommendations appropriate?
    Compston J
    Menopause Int; 2007 Jun; 13(2):54-5. PubMed ID: 17540133
    [No Abstract]   [Full Text] [Related]  

  • 10. Biophosphonate-related osteonecrosis of the jaws.
    Ruggiero SL; Woo SB
    Dent Clin North Am; 2008 Jan; 52(1):111-28, ix. PubMed ID: 18154867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral bisphosphonates.
    Zahrowski JJ
    J Am Dent Assoc; 2009 May; 140(5):517-8; author reply 518-9. PubMed ID: 19411514
    [No Abstract]   [Full Text] [Related]  

  • 12. Teriparatide therapy for denosumab-induced osteonecrosis of the jaw in a male osteoporotic patient.
    Neuprez A; Rompen E; Crielaard JM; Reginster JY
    Calcif Tissue Int; 2014 Jul; 95(1):94-6. PubMed ID: 24804929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diphosphonates can cause necrosis of the jaw. Patients with malignant skeletal diseases are at risk].
    Jarnbring F; Ulmner M; Blomlöf J; Ljungman P
    Lakartidningen; 2006 May 31-Jun 6; 103(21-22):1741-3. PubMed ID: 16826719
    [No Abstract]   [Full Text] [Related]  

  • 14. Osteonecrosis of the jaw after osteoporosis therapy with denosumab following long-term bisphosphonate therapy.
    Rachner TD; Platzbecker U; Felsenberg D; Hofbauer LC
    Mayo Clin Proc; 2013 Apr; 88(4):418-9. PubMed ID: 23541016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates: a potential threat to your patients.
    Dreiman BB
    J Indiana Dent Assoc; 2005-2006 Winter; 84(4):4-9. PubMed ID: 16605211
    [No Abstract]   [Full Text] [Related]  

  • 16. Teriparatide therapy for osteonecrosis of the jaw.
    Chtioui H; Lamine F; Daghfous R
    N Engl J Med; 2011 Mar; 364(11):1081-2; author reply 1082. PubMed ID: 21410382
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bisphosphonate-associated osteonecrosis of the jaws. 3. Two case reports].
    Schortinghuis J; Meijndert L; de Visscher JG; Witjes MJ
    Ned Tijdschr Tandheelkd; 2007 Oct; 114(10):432-5. PubMed ID: 17972612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate related osteonecrosis of the palate: report of a case managed with free tissue transfer.
    Engroff SL; Coletti D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 May; 105(5):580-2. PubMed ID: 18442742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orofacial pain - a presenting symptom of bisphosphonate associated osteonecrosis of the jaws.
    Srinivasan D; Shetty S; Ashworth D; Grew N; Millar B
    Br Dent J; 2007 Jul; 203(2):91-2. PubMed ID: 17660779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teriparatide for bone loss in the jaw.
    Grey A
    N Engl J Med; 2010 Dec; 363(25):2458-9. PubMed ID: 20950165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.